Kainic acid lesion-induced nigral neuronal death

Journal of Chemical Neuroanatomy

Volumn 26, Issue 1, 2003, Pages 65-73

  Foster, Jane A ^a,e   Bezin, Laurent ^b   Groc, Laurent ^a,b,c,d   Christopherson, Patricia L ^a   Levine, Robert A ^a,c,d  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b CNRS   (France)

^c WAYNE STATE UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Dopamine; Kainic acid; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

2,4 DIAMINO 6 HYDROXYPYRIMIDINE; DOPAMINE; ENZYME INHIBITOR; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; KAINIC ACID; LEVODOPA; TETRAHYDROBIOPTERIN; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; MALE; NERVE CELL NECROSIS; NERVE LESION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA;

EID: 0042261799     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-0618(03)00040-1     Document Type: Article

References (65)

1. Adams J.D. jr, Klaidman L.K., Ribeiro P. Tyrosine hydroxylase: mechanisms of oxygen radical formation. Redox Rep. 3:1997;273-279.
2. Anastasiadis P.Z., Kuhn D.M., Levine R.A. Tetrahydrobiopterin uptake into rat brain synaptosomes, cultured PC12 cells, and rat striatum. Brain Res. 665:1994;77-84.
3. Anastasiadis P.Z., Jiang H., Bezin L., Kuhn D.M., Levine R.A. Tetrahydrobiopterin enhances apoptotic PC12 cell death following withdrawal of trophic support. J. Biol. Chem. 276:2001;9050-9058.
4. Barde Y.A. Trophic factors and neuronal survival. Neuron. 2:1989;1525-1534.
5. Batistatou A., Greene L.A. Internucleosomal DNA cleavage and neuronal cell survival/death. J. Cell Biol. 122:1993;523-532.
6. Bezard E., Dovero S., Bioulac B., Gross C.E. Kinetics of nigral degeneration in a chronic model of MPTP-treated mice. Neurosci. Lett. 234:1997;47-50.
7. Brecknell J.E., Dunnett S.B., Fawcett J.W. A quantitative study of cell death in the substantia nigra following a mechanical lesion of the medial forebrain bundle. Neuroscience. 64:1995;219-227.
8. Burke R.E., Kholodilov N.G. Programmed cell death: does it play a role in Parkinson's disease. Ann. Neurol. 44:1998;S126-S133.
9. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4- phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA. 80:1983;4546-4550.
10. Cadet J.L., Katz M., Jackson-Lewis V., Fahn S. Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence. Brain Res. 476:1989;10-15.
11. Cho S., Volpe B.T., Bae Y., Hwang O., Choi H.J., Gal J., Park L.C., Chu C.K., Du J., Joh T.H. Blockade of tetrahydrobiopterin synthesis protects neurons after transient forebrain ischemia in rat: a novel role for the cofactor. J. Neurosci. 19:1999;878-889.
12. Choi H.J., Jang Y.J., Kim H.J., Hwang O. Tetrahydrobiopterin is released from and causes preferential death of catecholaminergic cells by oxidative stress. Mol. Pharmacol. 58:2000;633-640.
13. Clayton D.F., George J.M. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 21:1998;249-254.
14. Coyle J.T., Schwarcz R. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature. 263:1976;244-246.
15. Coyle J.T., Molliver M.E., Kuhar M.J. In situ injection of kainic acid: a new method for selectively lesioning neural cell bodies while sparing axons of passage. J. Comp. Neurol. 180:1978;301-323.
16. Divac I., Markowitsch H.J., Pritzel M. Behavioral and anatomical consequences of small intrastriatal injections of kainic acid in the rat. Brain Res. 151:1978;523-532.
17. Edwards S.N., Tolkovsky A.M. Characterization of apoptosis in cultured rat sympathetic neurons after nerve growth factor withdrawal. J. Cell Biol. 124:1994;537-546.
18. Foley P., Riederer P. Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease. J. Neurol. 247:(Suppl. 2):2000;II82-II94.
19. Fujikawa D.G. Confusion between neuronal apoptosis and activation of programmed cell death mechanisms in acute necrotic insults. Trends Neurosci. 23:2000;410-411.
20. 2 and 6-hydroxydopamine. Mov. Disord. 13:1998;661-667.
21. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
22. German D.C., Manaye K.F., Sonsalla P.K., Brooks B.A. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Ann. New York Acad. Sci. 648:1992;42-62.
23. Gibb W.R., Lees A.J. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 54:1991;388-396.
24. Gorczyca W., Gong J., Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53:1993;1945-1951.
25. Groc L., Levine R.A., Foster J.A., Normile H.J., Weissmann D., Bezin L. Evidence of deprenyl-insensitive apoptosis of nigral dopamine neurons during development. Brain Res. Develop. Brain Res. 120:2000;95-98.
26. Groc L., Bezin L., Foster J.A., Jiang H., Jackson T.S., Weissmann D., Levine R.A. Lipid peroxidation-mediated oxidative stress and dopamine neuronal apoptosis in the substantia nigra during development. Neurochem. Int. 39:2001;127-133.
27. Grunblatt E., Mandel S., Berkuzki T., Youdim M.B. Apomorphine protects against MPTP-induced neurotoxicity in mice. Mov. Disord. 14:1999;612-618.
28. Grunblatt E., Mandel S., Youdim M.B. MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies. J. Neurol. 247:(Suppl. 2):2000;II95-II102.
29. Haavik J., Almas B., Flatmark T. Generation of reactive oxygen species by tyrosine hydroxylase: a possible contribution to the degeneration of dopaminergic neurons. J. Neurochem. 68:1997;328-332.
30. Hastings T.G., Lewis D.A., Zigmond M.J. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA. 93:1996;1956-1961.
31. Heikkila R.E., Manzino L., Cabbat F.S., Duvoisin R.C. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature. 311:1984;467-469.
32. Hirsch E., Graybiel A.M., Agid Y.A. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature. 334:1988;345-348.
33. Hokfelt T., Ungerstedt U. Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system. Brain Res. 60:1973;269-297.
34. Javitch J.A., D'Amato R.J., Strittmatter S.M., Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA. 82:1985;2173-2177.
35. Javoy F., Sotelo C., Herbet A., Agid Y. Specificity of dopaminergic neuronal degeneration induced by intracerebral injection of 6-hydroxydopamine in the nigrostriatal dopamine system. Brain Res. 102:1976;201-215.
36. Krammer E.B. Anterograde and transsynaptic degeneration'en cascade' in basal ganglia induced by intrastriatal injection of kainic acid: an animal analogue of Huntington's disease. Brain Res. 196:1980;209-221.
37. Langston J.W., Irwin I., Langston E.B., Forno L.S. 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci. Lett. 48:1984;87-92.
38. Lee C.S., Schulzer M., Mak E.K., Snow B.J., Tsui J.K., Calne S., Hammerstad J., Calne D.B. Clinical observations on the rate of progression of idiopathic parkinsonism. Brain. 117:1994;501-507.
39. MacManus J.P., Hill I.E., Huang Z.G., Rasquinha I., Xue D., Buchan A.M. DNA damage consistent with apoptosis in transient focal ischaemic neocortex. Neuroreport. 5:1994;493-496.
40. McGeer E.G., McGeer P.L. Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids. Nature. 263:1976;517-519.
41. Mesner P.W., Winters T.R., Green S.H. Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons. J. Cell Biol. 119:1992;1669-1680.
42. Mesner P.W., Epting C.L., Hegarty J.L., Green S.H. A timetable of events during programmed cell death induced by trophic factor withdrawal from neuronal PC12 cells. J. Neurosci. 15:1995;7357-7366.
43. Nakao N., Nakai E., Nakai K., Itakura T. Ablation of the subthalamic nucleus supports the survival of nigral dopaminergic neurons after nigrostriatal lesions induced by the mitochondrial toxin 3-nitropropionic acid. Ann. Neurol. 45:1999;640-651.
44. Oppenheim R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:1991;453-501.
45. Pasinetti G.M., Morgan D.G., Finch C.E. Disappearance of GAD-mRNA and tyrosine hydroxylase in substantia nigra following striatal ibotenic acid lesions: evidence for transneuronal regression. Exp. Neurol. 112:1991;131-139.
46. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1998;Academic Press, London.
47. Perumal A.S., Gopal V.B., Tordzro W.K., Cooper T.B., Cadet J.L. Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain. Brain Res. Bull. 29:1992;699-701.
48. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 276:1997;2045-2047.
49. Portera-Cailliau C., Price D.L., Martin L.J. Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J. Comp. Neurol. 378:1997;70-87.
50. Roy M., Sapolsky R. Neuronal apoptosis in acute necrotic insults: why is this subject such a mess. Trends Neurosci. 22:1999;419-422.
51. Saji M., Reis D.J. Delayed transneuronal death of substantia nigra neurons prevented by gamma-aminobutyric acid agonist. Science. 235:1987;66-69.
52. Sauer H., Rosenblad C., Bjorklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. USA. 92:1995;8935-8939.
53. Schulzer M., Lee C.S., Mak E.K., Vingerhoets F.J., Calne D.B. A mathematical model of pathogenesis in idiopathic parkinsonism. Brain. 117:1994;509-516.
54. Schwarcz R., Coyle J.T. Striatal lesions with kainic acid: neurochemical characteristics. Brain Res. 127:1977;235-249.
55. Schwarcz R., Hokfelt T., Fuxe K., Jonsson G., Goldstein M., Terenius L. Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study. Exp. Brain Res. 37:1979;199-216.
56. Smith D.E., Saji M., Joh T.H., Reis D.J., Pickel V.M. Ibotenic acid-induced lesions of striatal target and projection neurons: ultrastructural manifestations in dopaminergic and non-dopaminergic neurons and in glia. Histol. Histopathol. 2:1987;251-263.
57. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature. 388:1997;839-840.
58. Spina M.B., Hyman C., Squinto S., Lindsay R.M. Brain-derived neurotrophic factor protects dopaminergic cells from 6-hydroxydopamine toxicity. Ann. New York Acad Sci. 648:1992;348-350.
59. Stokes A.H., Hastings T.G., Vrana K.E. Cytotoxic and genotoxic potential of dopamine. J. Neurosci. Res. 55:1999;659-665.
60. Tatton W.G. Selegiline can mediate neuronal rescue rather than neuronal protection. Mov. Disord. 8:1993;S20-S30.
61. Tatton W.G., Chalmers-Redman R.M., Ju W.Y., Wadia J., Tatton N.A. Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription. J. Neural Transm. Suppl. 49:1997;245-268.
62. Ungerstedt U. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5:1968;107-110.
63. Volpe B.T., Wildmann J., Altar C.A. Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions. Neuroscience. 83:1998;741-748.
64. Winkler C., Sauer H., Lee C.S., Bjorklund A. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 16:1996;7206-7215.
65. Xie L., Smith J.A., Gross S.S. GTP cyclohydrolase I inhibition by the prototypic inhibitor 2,4-diamino-6-hydroxypyrimidine. Mechanisms and unanticipated role of GTP cyclohydrolase I feedback regulatory protein. J. Biol. Chem. 273:1998;21091-21098.